Hongfei Wang

Henan Key Laboratory Of Immunology And Targeted Drugs
Xinxiang, 453003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Enhancing tumor immunotherapy with smart nanoparticles for reprogramming macrophages and blocking the CD47/Sirpα pathway.

Enhancing tumor immunotherapy with smart nanoparticles for reprogramming macrophages and blocking the CD47/Sirpα pathway.

Journal: Materials today. Bio

Published: March 20, 2025

EX527, a sirtuins 1 inhibitor, sensitizes T-cell leukemia to death receptor-mediated apoptosis by downregulating cellular FLICE inhibitory protein.

EX527, a sirtuins 1 inhibitor, sensitizes T-cell leukemia to death receptor-mediated apoptosis by downregulating cellular FLICE inhibitory protein.

Journal: Cancer biology & therapy

Published: September 17, 2024

LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression.

LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression.

Journal: Cellular & molecular biology letters

Published: September 24, 2023

Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy.

Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy.

Journal: Cell communication and signaling : CCS

Published: August 21, 2023

Identification of natural product 3, 5-diiodotyrosine as APOBEC3B inhibitor to prevent somatic mutation accumulation and cancer progression.

Identification of natural product 3, 5-diiodotyrosine as APOBEC3B inhibitor to prevent somatic mutation accumulation and cancer progression.

Journal: Journal for immunotherapy of cancer

Published: October 10, 2022

Enhancement of Proton Conductivity in Fe-Metal-Organic Frameworks by Postsynthetic Oxidation and High-Performance Hybrid Membranes with Low Acidity.

Enhancement of Proton Conductivity in Fe-Metal-Organic Frameworks by Postsynthetic Oxidation and High-Performance Hybrid Membranes with Low Acidity.

Journal: Inorganic chemistry

Published: December 09, 2021

Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK/STAT3 pathway.

Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK/STAT3 pathway.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 01, 2021

High Proton Conductivity in Nafion/Ni-MOF Composite Membranes Promoted by Ligand Exchange under Ambient Conditions.

High Proton Conductivity in Nafion/Ni-MOF Composite Membranes Promoted by Ligand Exchange under Ambient Conditions.

Journal: Inorganic chemistry

Published: July 02, 2021

Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-Therapy.

Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-Therapy.

Journal: Biomolecules

Published: March 14, 2021

Postsynthetic-Modified PANI/MOF Composites with Tunable Thermoelectric and Photoelectric Properties.

Postsynthetic-Modified PANI/MOF Composites with Tunable Thermoelectric and Photoelectric Properties.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: December 25, 2020

Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk/IL-21 axis.

Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk/IL-21 axis.

Journal: Theranostics

Published: November 25, 2020

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy.

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: September 03, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026